1. Cell Cycle/DNA Damage Apoptosis
  2. DNA/RNA Synthesis Apoptosis
  3. Supinoxin

Supinoxin  (Synonyms: RX-5902)

製品番号: HY-123611 純度: 99.67%
COA 取扱説明書 Technical Support

Supinoxin (RX-5902) is an orally active inhibitor of phosphorylated-p68 RNA helicase (P-p68) and a potent first-in-class anti-cancer agent. Supinoxin interacts with Y593 phosphorylated-p68 and attenuates the nuclear shuttling of β-catenin. Supinoxin induces cell apoptosis and inhibits growth of TNBC cancer cell lines with IC50s ranging from 10 nM to 20 nM.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

Supinoxin

Supinoxin 構造式

CAS 番号 : 888478-45-3

容量 価格(税別) 在庫状況 数量
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
USD 330 在庫あり
Solution
10 mM * 1 mL in DMSO USD 330 在庫あり
Solid
1 mg $142 在庫あり
5 mg $300 在庫あり
10 mg $450 在庫あり
25 mg $850 在庫あり
50 mg $1150 在庫あり
100 mg   お問い合わせ  
200 mg   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 0 publication(s) in Google Scholar

Top Publications Citing Use of Products

DNA/RNA Synthesis アイソフォーム固有の製品をすべて表示:

  • 生物活性

  • 純度とドキュメンテーション

  • 参考文献

  • カスタマーレビュー

製品説明

Supinoxin (RX-5902) is an orally active inhibitor of phosphorylated-p68 RNA helicase (P-p68) and a potent first-in-class anti-cancer agent. Supinoxin interacts with Y593 phosphorylated-p68 and attenuates the nuclear shuttling of β-catenin. Supinoxin induces cell apoptosis and inhibits growth of TNBC cancer cell lines with IC50s ranging from 10 nM to 20 nM[1][2].

IC50 & Target

Helicase

 

Cellular Effect
Cell Line Type Value Description References
A549 IC50
0.021 μM
Compound: 25
Growth inhibition of human A549 cells after 96 hrs by sulforhodamine B assay
Growth inhibition of human A549 cells after 96 hrs by sulforhodamine B assay
[PMID: 20943401]
CAKI-1 IC50
0.011 μM
Compound: 25
Growth inhibition of human Caki1 cells after 96 hrs by sulforhodamine B assay
Growth inhibition of human Caki1 cells after 96 hrs by sulforhodamine B assay
[PMID: 20943401]
HCT-116 IC50
0.02 μM
Compound: 25
Growth inhibition of human HCT116 cells after 96 hrs by sulforhodamine B assay
Growth inhibition of human HCT116 cells after 96 hrs by sulforhodamine B assay
[PMID: 20943401]
HCT-15 IC50
21 nM
Compound: 25
Growth inhibition of human HCT15 cells after 96 hrs by sulforhodamine B assay
Growth inhibition of human HCT15 cells after 96 hrs by sulforhodamine B assay
[PMID: 20943401]
HT-29 IC50
0.021 μM
Compound: 25
Growth inhibition of human HT-29 cells after 96 hrs by sulforhodamine B assay
Growth inhibition of human HT-29 cells after 96 hrs by sulforhodamine B assay
[PMID: 20943401]
HeLa IC50
0.021 μM
Compound: 25
Growth inhibition of human HeLa cells after 96 hrs by sulforhodamine B assay
Growth inhibition of human HeLa cells after 96 hrs by sulforhodamine B assay
[PMID: 20943401]
HepG2 IC50
0.019 μM
Compound: 25
Growth inhibition of human HepG2 cells after 96 hrs by sulforhodamine B assay
Growth inhibition of human HepG2 cells after 96 hrs by sulforhodamine B assay
[PMID: 20943401]
MDA-MB-231 IC50
0.012 μM
Compound: 25
Growth inhibition of human MDA-MB-231 cells after 96 hrs by sulforhodamine B assay
Growth inhibition of human MDA-MB-231 cells after 96 hrs by sulforhodamine B assay
[PMID: 20943401]
MKN-45 IC50
0.02 μM
Compound: 25
Growth inhibition of human MKN45 cells after 96 hrs by sulforhodamine B assay
Growth inhibition of human MKN45 cells after 96 hrs by sulforhodamine B assay
[PMID: 20943401]
OVCAR-3 IC50
0.012 μM
Compound: 25
Growth inhibition of human OVCAR-3 cells after 96 hrs by sulforhodamine B assay
Growth inhibition of human OVCAR-3 cells after 96 hrs by sulforhodamine B assay
[PMID: 20943401]
PANC-1 IC50
0.021 μM
Compound: 25
Growth inhibition of human PANC1 cells after 96 hrs by sulforhodamine B assay
Growth inhibition of human PANC1 cells after 96 hrs by sulforhodamine B assay
[PMID: 20943401]
PC-3 IC50
0.021 μM
Compound: 25
Growth inhibition of human PC3 cells after 96 hrs by sulforhodamine B assay
Growth inhibition of human PC3 cells after 96 hrs by sulforhodamine B assay
[PMID: 20943401]
SK-MEL-28 IC50
0.02 μM
Compound: 25
Growth inhibition of human SK-MEL-28 cells after 96 hrs by sulforhodamine B assay
Growth inhibition of human SK-MEL-28 cells after 96 hrs by sulforhodamine B assay
[PMID: 20943401]
U-251 IC50
0.015 μM
Compound: 25
Growth inhibition of human U251 cells after 96 hrs by sulforhodamine B assay
Growth inhibition of human U251 cells after 96 hrs by sulforhodamine B assay
[PMID: 20943401]
体外実験

RX-5902 (0-10 μM; 72 hours) is active against cell lines of all TNBC molecular subtypes and is active against cell lines with mutations in p53, RB1, CDKN2A, and loss of PTEN[1].
RX-5902 (20-100 nM; 24 hours) treatment results in a dose-dependent increase in tetraploid cells, consistent with induction of G2–M cell-cycle arrest[1].
RX-5902 (0-100 nM; 72 hours) exhibits no significant induction of apoptosis in cell lines resistant to the antiproliferative effects of RX5902. But in sensitive cells, the observed activation of apoptosis begins at 24–48 hours and reaches a peak at 72 hours. The induced apoptosis is greasted with a dose of 100 nM[1].
RX-5902 (0-100 nM; 24 or 48 hours) decreases MCL-1 expression as a dose-dependent manner in TNBC cell lines sensitive to RX-5902[1].
RX-5902 inhibits cell growth, MDA-MB-231, Caki-1, UMRC2, PANC-1, A549, MKN-45, HepG2, HCT116, HT29, PC-3, U251, HeLa, SK-MEL-28 and OVCAR-3 with IC50 values range from 0.01 μM to 0.021 μM in the growth inhibition of cancer cells[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[1]

Cell Line: MDA-MB-231, HCC1806, Hs578t, CAL-85-1, HCC38, HCC1187, MDA-MB-436, CAL-51, HCC38, BT549, MDAMB-157, HDQ-P1, HCC1395, MDA-MB-436, HCC1937, CAL-120, BT20 cells
Concentration: 0-10 μM
Incubation Time: 72 hours
Result: Displayed the average IC50 of the cell lines sensitive to RX-5902 treatment is 56 nM.

Cell Cycle Analysis[1]

Cell Line: Sensitive (MDA-MB-231 and HCT1806) and two resistant (MDA-MB-436 and CAL-120) cell lines
Concentration: 20 nM; 100 nM
Incubation Time: 24 hours
Result: Led to G2-M cell-cycle arrest at sensitive cells.

Apoptosis Analysis[1]

Cell Line: Sensitive (MDA-MB-231 and HCT1806) and two resistant (MDA-MB-436 and CAL-120) cell lines
Concentration: 0-100 nM
Incubation Time: 24-72 hours
Result: Induced cell apoptosis in sensitive cell lines and peaks at 72 hours.

Western Blot Analysis[1]

Cell Line: Cal-51, HCC-1806, and MDA-MB-468 cells
Concentration: 20 nM; 100 nM
Incubation Time: 24 hours
Result: Induced inhibition of MCL-1 expression in Cal-51, HCC-1806, and MDA-MB-468 cells.
体内実験

RX-5902 (oral administration; 160/320/600 mg/kg; once weekly for 3 weeks) significant dose-dependent tumor growth inhibition (TGI) in the MDA-MB-231 model, exhibits TGI of 55.7%, 80.29% and 94.58% at 160 mg/kg, 320 mg/kg and 600 mg/kg, respectively. It is more efficacious than the chemotherapy control arm of nab-paclitaxel (TGI 45%)[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: MDAMD-231 xenograft model in mice[1]
Dosage: 160 mg/kg; 320 mg/kg; 600 mg/kg
Administration: Oral administration; once weekly for 3 weeks
Result: Decreased tumor volume as a dose-dependent manner.
臨床実験
分子量

441.46

分子式

C22H24FN5O4

CAS 番号
Appearance

Solid

Color

White to off-white

SMILES

O=C(N1CCN(C2=CC(OC)=CC(OC)=C2)CC1)NC3=NC4=CC(F)=CC=C4N=C3OC

輸送条件

Room temperature in continental US; may vary elsewhere.

保管条件
Powder -20°C 3 years
  4°C 2 years
In solvent -80°C 6 months
  -20°C 1 month
溶剤 & 溶解度
体外: 

DMSO : 100 mg/mL (226.52 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.2652 mL 11.3261 mL 22.6521 mL
5 mM 0.4530 mL 2.2652 mL 4.5304 mL
10 mM 0.2265 mL 1.1326 mL 2.2652 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

一般には略語で表示されます:C1V1 = C2V2

濃度 (開始)

C1

×
体積 (開始)

V1

=
濃度 (終了)

C2

×
体積 (終了)

V2

体内:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

  • Protocol 1

    Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

    Solubility: ≥ 2.5 mg/mL (5.66 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

    Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
  • Protocol 2

    Add each solvent one by one:  10% DMSO    90% Corn Oil

    Solubility: ≥ 2.5 mg/mL (5.66 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL Corn oil, and mix evenly.

In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
%
DMSO +
+
%
Tween-80 +
%
Saline
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Calculation results:
Working solution concentration: mg/mL
Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).
The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
 If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
純度とドキュメンテーション

純度: 99.67%

参考文献

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 2.2652 mL 11.3261 mL 22.6521 mL 56.6303 mL
5 mM 0.4530 mL 2.2652 mL 4.5304 mL 11.3261 mL
10 mM 0.2265 mL 1.1326 mL 2.2652 mL 5.6630 mL
15 mM 0.1510 mL 0.7551 mL 1.5101 mL 3.7754 mL
20 mM 0.1133 mL 0.5663 mL 1.1326 mL 2.8315 mL
25 mM 0.0906 mL 0.4530 mL 0.9061 mL 2.2652 mL
30 mM 0.0755 mL 0.3775 mL 0.7551 mL 1.8877 mL
40 mM 0.0566 mL 0.2832 mL 0.5663 mL 1.4158 mL
50 mM 0.0453 mL 0.2265 mL 0.4530 mL 1.1326 mL
60 mM 0.0378 mL 0.1888 mL 0.3775 mL 0.9438 mL
80 mM 0.0283 mL 0.1416 mL 0.2832 mL 0.7079 mL
100 mM 0.0227 mL 0.1133 mL 0.2265 mL 0.5663 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

質量   濃度   体積   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

一般には略語で表示されます:C1V1 = C2V2

濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

最近チェックした製品:

オンラインお問い合わせ

Your information is safe with us. * Required Fields.

製品名

 

カスタマ需要量 *

お名前 *

 

タイトル

メールアドレス *

 

電話番号 *

デパートメント

 

組纖名 *

市区町村

都道府県

国或いは地域 *

     

必ず会社名を記載ください。個人への返信は行いません。

備考

バルクお問い合わせ

Inquiry Information

製品名:
Supinoxin
製品番号:
HY-123611
数量:
MCE 日本正規代理店: